Technology News and Research

RSS

Biomedical engineering professor receives patent for Electromagnetic Probe Device

The United States Patent Office has issued a patent to Dr. Mark DeCoster, associate professor of biomedical engineering at Louisiana Tech University, for his invention of an "Electromagnetic Probe Device" - an innovative technology developed at Louisiana Tech's Institute for Micromanufacturing.

4 Aug 2010

GE and Intel create new health IT venture focused on home-based care

General Electric Co. and Intel Corp. announced Monday they will create a company to provide new medical technologies for the elderly and chronically ill.

4 Aug 2010

Spectrum Health selects Aternity FPI Platform for strategic end user experience management initiatives

Aternity Inc., the industry's technology leader in end user experience management solutions for Global 1000 enterprises, announced today that Spectrum Health, a not-for-profit health system in West Michigan that offers a full continuum of care that includes the Spectrum Health Hospital Group, has selected the Aternity Frontline Performance Intelligence (FPI) Platform for its strategic end user experience management initiatives.

4 Aug 2010

New algorithm to reduce radiation dose in CT imaging

In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia. The presentation was entitled "20-Fold Dose Reduction Using a Gradient Adaptive Bilateral Filter: Demonstration Using in Vivo Animal Perfusion CT."

4 Aug 2010

BARDA awards contract to develop Pfenex Expression Technology

Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA) has awarded Pfenex a contract providing for up to a total of $18.8 million in funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government. The contract will support the development of a robust Pfenex Expression Technology based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax.

4 Aug 2010

Celera decreases second-quarter net loss to $6.1 million

Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.

4 Aug 2010

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

SGI, a global leader in HPC and data center solutions, today announced that the Queensland Centre for Medical Genomics at the University of Queensland has selected SGI LiveArc storage solution to increase its ability to store, manage and process human cancer genome sequence data. This project will contribute to mapping the genetic changes that lead to cancer, providing better understanding of such cancers and potentially helping to combat the disease.

4 Aug 2010

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector.

4 Aug 2010

Smokefree enters joint venture with Colorado to market smoke-free pharmacological products

Smokefree Innotec, Inc. Thomas Schroepfer, CEO, announced today that the Company has executed a Joint venture agreement with a Colorado research and development corporation focusing on natural holistic and herbal medical compounds, operating out of laboratory facilities located in Colorado Springs. The business objective is to jointly develop and market several smoke-free high tech natural and herbal pharmacological products, initially based upon an oral delivery system utilizing the innovative technology developed for the "REAL Smokefree Cigarette". Under this joint venture Smokefree Innotec, Inc. will provide its smoke-free products and devices, and its venture partner will provide all the medical extract formulations to the Company.

4 Aug 2010

Hospitals, docs adopting health IT ahead of schedule

Clinics and hospitals are increasingly switching to electronic medical records as a federal push to spread the technology sweeps across the nation.

4 Aug 2010

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.

4 Aug 2010

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

The Baylor College of Medicine Human Genome Sequencing Center has standardized its target enrichment human disease research studies on Roche NimbleGen Sequence Capture Exome technology. The Baylor HGSC will sequence over 5,000 exomes in the next two years to identify genetic variants underlying multiple human diseases and will employ NimbleGen SeqCap EZ Exome and customized NimbleGen exome designs as the exome capture technology of choice. More than 15 different diseases will be investigated by Baylor HGSC, including brain, liver, pancreatic, colon, ovarian and bladder cancers, heart disease, diabetes, autism, and other inherited diseases with the goal of better understanding causative mutations and their impact on these diseases.

4 Aug 2010

Cornerstone licenses global rights to alpha-7 technology to Targacept

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.

4 Aug 2010

Agilent Technologies signs MoU with Government of Malaysia to intensify IPHARM's research activities

Agilent Technologies Inc. today signed a Memorandum of Understanding (MoU) with the Government of Malaysia through the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPHARM), an agency under the Ministry of Science, Technology and Innovation (MOSTI), to promote and develop cooperation in biotechnology.

4 Aug 2010

Enzon second-quarter loss from continuing operations reduces to $5.4 million

Enzon Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2010. For the second quarter of 2010, Enzon reported a loss from continuing operations of $5.4 million or $0.09 per diluted share, as compared to a loss of $19.7 million or $0.43 per diluted share for the second quarter of 2009.

4 Aug 2010

One-on-one talk with therapist reduces peer aggression

A brief, motivational talk in the emergency room reduced by half the chances that teenagers would experience peer violence or problems due to drinking, according to a study published Aug. 4 in a theme issue of the Journal of the American Medical Association.

4 Aug 2010

CSI launches Diamondback Predator 360 catheter system for treatment of peripheral arterial disease

Cardiovascular Systems, Inc. has launched its second-generation product, the Diamondback Predator 360° PAD System, for the treatment of peripheral arterial disease (PAD). The new device uses the same mechanism of action as the clinically proven Diamondback 360 PAD System with improvements in the crowns and shaft for enhanced clinical performance and shorter procedure times.

4 Aug 2010

Accuray receives Shonin approval to market CyberKnife G4 Robotic Radiosurgery System

Accuray Incorporated, a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare to market the CyberKnife G4 Robotic Radiosurgery System to treat tumors non-invasively anywhere in the body, inclusive of head and neck. The System will be marketed in Japan as the "CyberKnife Radiosurgery System."

3 Aug 2010

ImpactRx launches smart-phone application for physicians

ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.

3 Aug 2010

Kopin second-quarter total sales increase 7.0% to $30.2 million

Kopin Corporation today announced financial results for the second quarter ended June 26, 2010.

3 Aug 2010

Technology News and Research

Biomedical engineering professor receives patent for Electromagnetic Probe Device

GE and Intel create new health IT venture focused on home-based care

Spectrum Health selects Aternity FPI Platform for strategic end user experience management initiatives

New algorithm to reduce radiation dose in CT imaging

BARDA awards contract to develop Pfenex Expression Technology

Celera decreases second-quarter net loss to $6.1 million

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

Smokefree enters joint venture with Colorado to market smoke-free pharmacological products

Hospitals, docs adopting health IT ahead of schedule

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

Cornerstone licenses global rights to alpha-7 technology to Targacept

Agilent Technologies signs MoU with Government of Malaysia to intensify IPHARM's research activities

Enzon second-quarter loss from continuing operations reduces to $5.4 million

One-on-one talk with therapist reduces peer aggression

CSI launches Diamondback Predator 360 catheter system for treatment of peripheral arterial disease

Accuray receives Shonin approval to market CyberKnife G4 Robotic Radiosurgery System

ImpactRx launches smart-phone application for physicians

Kopin second-quarter total sales increase 7.0% to $30.2 million

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News